Health Canada warns of 'rare' SJS reports with Pfizer's Sutent
This article was originally published in Scrip
Executive Summary
Health Canada on 6 September warned healthcare providers about the potential risk of Steven's-Johnson syndrome, a life-threatening disorder in which the top layers of the skin begin to die, and toxic epidermal necrolysis (TEN), a severe form of SJS, in patients given Pfizer's cancer drug Sutent (sunitinib malate).